Par’s Generic Parnate Is On Par, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Par Pharmaceutical's subsidiary Kali Laboratories received FDA final approval for its generic Parnate (tranylcypromine sulfate) 10 mg June 29